Recombinant Human Fractalkine (CX3CL1) was expressed in E. coli cells.
Catalog No. F870-40N
Catalog No. | Pack Size | Price (USD) | |
---|---|---|---|
F870-40N-20 | 20 ug | $395 | |
F870-40N-BULK | BULK | Contact Us |
Overview:
Fractalkine is a type I membrane protein that signals through the CX3CR1 receptor. The extracellular domain of Fractalkine is released by protease cleavage – producing soluble Fractalkine. Fractalkine has been found in many tissues and shown to be up-regulated in endothelial cells and microglia in response to inflammatory signals. Fractalkine is also involved in leukocyte adhesion as well as attracting monocytes, microglia cells and NK cells.
Gene Aliases:
C-X3-C motif chemokine 1, CX3C membrane-anchored chemokine, Neurotactin, Small-inducible cytokine D1.
Genbank Number:
Storage, Stability and Shipping:
The lyophilized protein is stable for at least one year from date of receipt at -70oC. Upon reconstitution, this cytokine can be stored in working aliquots at 2o - 8oC for one month, or at -20oC for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles.
Endotoxin Level:
<1.0 EU/μg of recombinant protein as determined by the LAL method.
Molecular Weight:
8.9 kDa
Reconstitution Protocol:
Reconstitute at 25 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.
Sample Cell Assay Data:
Measured by its ability to chemoattract BaF3 mouse pro-B cells transfected with mouse CX3CR1. The ED(50) for this effect is typically 20100 ng/mL
Purity:
Recombinant Human Fractalkine(CX3CL1) resolved on a 17% SDS_PAGE gel under reducing conditions and stained with Coomassie Brilliant Blue G-250.
There are no related publications available for this product.
STAY CONNECTED
Fax: 1-604-232-4601